Molecular
detection of disease-associated mutations, especially
those with low abundance, is essential for academic research and clinical
diagnosis. Certain variant detection methods reach satisfactory sensitivity
and specificity in detecting rare mutations based on the introduction
of blocking oligos to prevent the amplification of wild-type or unwanted
templates, thus selectively amplifying and enriching the mutations.
These blocking oligos usually suppress PCR amplification through the
3′ chemical modifications, with high price, slow synthesis,
and reduced purity. Herein, we introduce chemistry-free designs to
block enzymatic extension during PCR by the steric hindrance from
the secondary structures attached to the 3′ end of the oligos
(nonextensible oligonucleotide, NEO). We demonstrated that NEO efficiently
prohibited the extension of both Taq and high-fidelity DNA polymerases.
By further applying NEO as blockers in blocker displacement amplification
(BDA) qPCR, multiplex BDA (mBDA) NGS, and quantitative BDA (QBDA)
NGS methods, we showed that NEO blockers had performance comparable
with previously validated chemical modifications. Comparison experiments
using QBDA with NEO blockers and droplet digital PCR (ddPCR) on clinical
formalin-fixed paraffin-embedded (FFPE) samples exhibited 100% concordance.
Lastly, the ability of NEO to adjust plex uniformity through changes
of PCR amplification efficiency was demonstrated in an 80-plex NGS
panel.